Prime Medicine (NASDAQ: PRME) net income
Prime Medicine reported a net loss of $201.1m for fiscal 2025; in fiscal 2024 it reported a net loss of $195.9m. Earnings per share were −$1.35.
Prime Medicine's best year of the last 5 was fiscal 2022. It reported a loss in 5 of those 5 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$201.1m | — | −4,342.4% | −$1.35 |
| 2024 | −$195.9m | — | −6,566.6% | −$1.65 |
| 2023 | −$198.1m | — | — | −$2.18 |
| 2022 | −$121.8m | — | — | −$4.19 |
| 2021 | −$165.4m | — | — | −$14.19 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Prime Medicine net income compared with its sector
By net income for its latest fiscal year, Prime Medicine ranks 410th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Prime Medicine, −4,342.4%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 408th | Rhythm Pharmaceuticals | −$196.5m | −103.6% |
| 409th | Teladoc Health | −$200.3m | −7.9% |
| 410th | Prime Medicine | −$201.1m | −4,342.4% |
| 411th | Wave Life Sciences | −$204.4m | −478.3% |
| 412th | Nuvation Bio | −$204.6m | −325.3% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Prime Medicine
- How much did Prime Medicine earn in fiscal 2025?
- Prime Medicine reported a net loss of $201.1m for fiscal 2025. In fiscal 2024 it reported a net loss of $195.9m.
- What are the earnings per share of Prime Medicine?
- They were −$1.35 in fiscal 2025, compared with −$1.65 in fiscal 2024.
- Where does Prime Medicine rank in its sector by net income?
- It ranks 410th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Prime Medicine come from?
- From the annual report (Form 10-K) that Prime Medicine files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Prime Medicine files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021. More on Prime Medicine: the Prime Medicine page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.